In March 2025, the company announced new options for your direct-to-client supplying of its Wegovy weight loss drug. The company proven a fresh pharmacy, referred to as NovoCare, which would demand buyers $499 per month for usage of the drug, a lot less than 50 % the expense of the drug via other pharmaceutical distribution networks.[fifty three]in